Skip to main content
S. 2282 114th Congress Senate

Stem Cell Therapeutic and Research Reauthorization Act of 2015

Official title: A bill to amend the Public Health Service Act to reauthorize the C.W. Bill Young Cell Transplantation Program and the National Cord Blood Inventory, and for other purposes.

Introduced: November 16, 2015 See on congress.gov
Health Administrative law and regulatory proceduresBlood and blood diseasesCell biology and embryologyDepartment of Health and Human Services
More subjectsShow fewer subjects
Health programs administration and fundingMedical researchOrgan and tissue donation and transplantationPublic contracts and procurementResearch administration and funding
Sign in to write a letter

Free account. One morning email at most, only on days something moved. Already have one? Sign in.

This bill died when the 114th Congress ended
It never became law before the 114th Congress (2015–2016) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Nov 16, 2015
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S7968-7969)
Nov 16, 2015
Introduced in Senate
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action November 16, 2015

Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S7968-7969)

 Plain-English summary Congressional Research Service

Stem Cell Therapeutic and Research Reauthorization Act of 2015

This bill amends the Public Health Service Act and the Stem Cell Therapeutic and Research Act of 2005 to revise and extend through FY2020 the C.W. Bill Young Cell Transplantation Program and the National Cord Blood Inventory program. (These programs help match patients in need of a transplant with unrelated bone marrow and cord blood donors.)

The Department of Health and Human Services (HHS) must review the state of the science of using adult stem cells and birthing tissues to develop new therapies and consider the inclusion of new therapies in the C.W. Bill Young Cell Transplantation Program.

Requirements for HHS contracts under the Stem Cell Therapeutic and Research Act of 2005 are revised.

HHS must determine whether to include peripheral blood stem cells and umbilical cord blood in the definition of human organ.
 Related & companion bills 1
  • HR 2820 Stem Cell Therapeutic and Research Reauthorization Act of 2015
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 1
 Cosponsors 2
All 2 Democratic 1
Burr, Richard
· Nov 16, 2015
 D
Reed, Jack
Rhode Island · Nov 16, 2015
Cite this page click to expand
APA
U.S. Congress. (2026). S. 2282: Stem Cell Therapeutic and Research Reauthorization Act of 2015. 114th Congress. Open America. https://openamerica.io/bill/114-S-2282/
MLA
"S. 2282: Stem Cell Therapeutic and Research Reauthorization Act of 2015." 114th Congress, 2026, Open America, https://openamerica.io/bill/114-S-2282/.
Bluebook (legal)
S. 2282, 114th Cong. (2026), https://openamerica.io/bill/114-S-2282/.
Markdown link
[S. 2282: Stem Cell Therapeutic and Research Reauthorization Act of 2015](https://openamerica.io/bill/114-S-2282/)
Report a problem